| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 19.860 | 13.692 | 20.260 | 23.038 | 23.142 | 26.152 |
| Total Income - EUR | - | - | - | 0 | 19.861 | 13.725 | 20.267 | 23.038 | 23.142 | 26.264 |
| Total Expenses - EUR | - | - | - | 1.478 | 10.671 | 4.954 | 7.225 | 15.891 | 17.254 | 18.870 |
| Gross Profit/Loss - EUR | - | - | - | -1.478 | 9.190 | 8.771 | 13.041 | 7.147 | 5.888 | 7.395 |
| Net Profit/Loss - EUR | - | - | - | -1.478 | 8.650 | 8.443 | 12.597 | 6.697 | 5.094 | 6.386 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medbiv S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 28.160 | 20.588 | 13.028 |
| Current Assets | - | - | - | 3.479 | 6.592 | 13.271 | 17.524 | 9.140 | 8.590 | 7.222 |
| Inventories | - | - | - | 3.273 | 249 | 0 | 0 | 1.210 | 1.011 | 161 |
| Receivables | - | - | - | 0 | 2.055 | 1 | 486 | 203 | 359 | 447 |
| Cash | - | - | - | 206 | 4.288 | 13.270 | 17.038 | 7.726 | 7.221 | 6.614 |
| Shareholders Funds | - | - | - | -1.435 | 7.243 | 15.548 | 19.715 | 16.334 | 16.325 | 17.157 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 4.914 | 1.401 | 191 | 101 | 23.127 | 14.882 | 4.914 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medbiv S.r.l.